77 related articles for article (PubMed ID: 19850311)
1. Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice.
Li GX; Zhou YJ; Yu H; Tian ZJ; Yan LP; Zhang Q; Hu SP; Tong GZ
Res Vet Sci; 2010 Apr; 88(2):345-51. PubMed ID: 19850311
[TBL] [Abstract][Full Text] [Related]
2. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
[TBL] [Abstract][Full Text] [Related]
3. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge.
Tian ZJ; Zhou GH; Zheng BL; Qiu HJ; Ni JQ; Yang HL; Yin XN; Hu SP; Tong GZ
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):211-8. PubMed ID: 16621018
[TBL] [Abstract][Full Text] [Related]
4. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
Tang M; Harp JA; Wesley RD
Arch Virol; 2002 Nov; 147(11):2125-41. PubMed ID: 12417948
[TBL] [Abstract][Full Text] [Related]
6. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
[TBL] [Abstract][Full Text] [Related]
7. [C3d-M28 enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus].
Fan H; Liu Z; Tong T; Liu X; Guo A
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):987-92. PubMed ID: 19835138
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
9. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
10. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
11. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
[TBL] [Abstract][Full Text] [Related]
14. Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus.
Zhang D; Xia Q; Wu J; Liu D; Wang X; Niu Z
Vaccine; 2011 Jan; 29(4):629-35. PubMed ID: 21134449
[TBL] [Abstract][Full Text] [Related]
15. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
Kitikoon P; Strait EL; Thacker EL
Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
17. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
Wesley RD; Tang M; Lager KM
Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
19. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
Ze C; Kurata T; Tamura S
Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
[TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
